← Eichor
Study identifier: NCT06076083 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Multi-omics Database for Integrative Microbiome Analysis in a Cohort of Korean Patients With Ankylosing Spondylitis

Condition: Ankylosing Spondylitis  ·  Sponsor: Tae-Hwan Kim

PhaseN/A
Planned participants600
Who can joinAll sexes, 19 Years to 60 Years
Healthy volunteersNo

About this study

Multicenter Human Derivatives Prospective Cohort Study: Clinical information will be collected from patients with ankylosing spondylitis and their families who have provided research consent. And clinical samples including blood, saliva, feces, and mucosal biopsy tissue (from patients scheduled for sigmoid colonoscopy or routine colonoscopy examinations) will be collected. Multi-omics data production and laboratory analysis will be conducted using the collected samples, followed by integrated bioinformatic analysis using the produced data."

This description comes directly from the study's public registry record.

Talk to the study team

Tae-Hwan Kim, MD,PhD  ·  82-2-2290-9245  ·  thkim@hanyang.ac.kr

Ji-Hui Shin, MS  ·  82-2-2290-9252  ·  sjihui@hanyang.ac.kr

Always discuss trial participation with your own doctor first.

Locations (2)

Kyung Hee University Medical CenterSeoul, Kyungheedae-ro 23, South KoreaRecruiting
Hanyang University Hospital for Rheumatic DiseasesSeoul, Wangsimni-ro222-1, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06076083